Page last updated: 2024-11-02

oxybutynin and Adenoma, Pleomorphic

oxybutynin has been researched along with Adenoma, Pleomorphic in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Adenoma, Pleomorphic: A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becelli, R1
Morello, R1
Renzi, G1
Matarazzo, G1

Trials

1 trial available for oxybutynin and Adenoma, Pleomorphic

ArticleYear
Use of scopolamine patches in patients treated with parotidectomy.
    The Journal of craniofacial surgery, 2014, Volume: 25, Issue:1

    Topics: Adenoma, Pleomorphic; Combined Modality Therapy; Drainage; Humans; Parotid Gland; Parotid Neoplasms;

2014